Publications by authors named "Ninan T Mathew"

Claim this Profile
C
Cluster headache and other trigeminal autonomic cephalalgias diagnostic criteria.
Ninan T Mathew

Handb Clin Neurol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, controlled study of telcagepant in patients with migraine and coronary artery disease.
Tony W Ho, Andrew P Ho, Bernard R Chaitman, Constance Johnson, Ninan T Mathew

Headache· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of MAP0004, orally inhaled DHE in treating migraines with and without allodynia.
Stewart J Tepper, Shashidhar H Kori, Scott W Borland, Min H Wang, Bin Hu, Ninan T Mathew

Headache· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathophysiology of chronic migraine and mode of action of preventive medications.
Ninan T Mathew

Headache· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study.
Ninan T Mathew, Sayyed Farhan A Jaffri

Headache· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying the return of headache in triptan-treated migraineurs: an observational study.
Fred Sheftell, Mary Almas, Randall Weeks, Ninan T Mathew, Verne Pitman

Cephalalgia· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A practice guide for continuous opioid therapy for refractory daily headache: patient selection, physician requirements, and treatment monitoring.
Joel R Saper, Alvin E Lake, Philip A Bain, Mark J Stillman, John F Rothrock, Ninan T Mathew

Headache· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
Ninan T Mathew, Stephen Landy, Stuart Stark, Gretchen E Tietjen, Frederick J Derosier

Headache· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allodynia-associated symptoms, pain intensity and time to treatment: predicting treatment response in acute migraine intervention.
Roger K Cady, Frederick G Freitag, Ninan T Mathew, Arthur H Elkind, Lian Mao

Headache· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic optimization of chronic migraine treatment: current and future options.
Ninan T Mathew

Neurology· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial.
Steven L Linder, Ninan T Mathew, Roger K Cady, Gary Finlayson, Gary Ishkanian

Headache· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational combination therapy in refractory migraine.
B Lee Peterlin, Anne H Calhoun, Sherry Siegel, Ninan T Mathew

Headache· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of questions to determine the presence of photophobia and phonophobia during migraine.
Randolph W Evans, Tad Seifert, Jayasree Kailasam, Ninan T Mathew

Headache· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Botulinum toxin type A for the treatment of nummular headache: four case studies.
Ninan T Mathew, Jayasree Kailasam, Lori Meadors

Headache· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of topiramate on health-related quality of life indicators in chronic migraine.
David W Dodick, Stephen Silberstein, Joel Saper, Fred G Freitag, Roger K Cady, Ninan T Mathew

Headache· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of response to botulinum toxin type A (BoNTA) in chronic daily headache.
Ninan T Mathew, Jayasree Kailasam, Lori Meadors

Headache· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A double-blind, randomized, placebo-controlled comparison of botulinum toxin type a injection sites and doses in the prevention of episodic migraine.
Joel R Saper, Ninan T Mathew, Elizabeth W Loder, Ronald DeGryse, Amanda M VanDenburgh

Pain Med· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
Ninan T Mathew, Gary Finlayson, Timothy R Smith, Roger K Cady, James Adelman

Headache· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prophylactic treatment of chronic daily headache.
Ninan T Mathew

Headache· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tension-type headache.
Ninan T Mathew

Curr Neurol Neurosci Rep· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of almotriptan in controlled clinical trials.
Ninan T Mathew

Eur Neurol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are triptans effective and safe when taken during the aura phase of migraine?
Randolph W Evans, Tad Seifert, Ninan T Mathew

Headache· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.
Ninan T Mathew, Benjamin M Frishberg, Marek Gawel, Rozalina Dimitrova, John Gibson

Headache· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the triptans.
Ninan T Mathew, Elizabeth W Loder

Am J Med· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical recognition of allodynia in migraine.
Ninan T Mathew, Jayasree Kailasam, Tad Seifert

Neurology· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis